New article regarding Endocrine Disruptors

Human health impact and cost estimates attributed to endocrine disrupting chemical exposure completely unfounded, researchers show

A series of economic papers released in 2015 and 2016 estimating the burden of diseases and associated costs attributable to exposure to endocrine disrupting chemicals (EDCs) in the U.S. and EU are as flawed and immaterial to public health decision-making as many experts first suspected, according to a thorough and rigorous critique of the underlying methodology used to generate the cost estimates published this month in the online version of the influential, peer-reviewed journal Archives of Toxicology.

For further details, see the attached articles to the right.